BRCA1 and ovarian cancer: The ID8 Trp53-/- Brca1-/- model has mutations commonly found in patients with the high-grade serous subtype of ovarian cancer and is highly metastatic as mice injected with cancer cells orthotopically (intrabursal) succumb to disease due to peritoneal dissemination and ascites accumulation (33, 34).